Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
Research ArticleOriginal Research

Comparing Very Low-Carbohydrate vs DASH Diets for Overweight or Obese Adults With Hypertension and Prediabetes or Type 2 Diabetes: A Randomized Trial

Laura R. Saslow, Lenette M. Jones, Ananda Sen, Julia A. Wolfson, Heidi L. Diez, Alison O’Brien, Cindy W. Leung, Hovig Bayandorian, Jennifer Daubenmier, Amanda L. Missel and Caroline Richardson
The Annals of Family Medicine May 2023, 21 (3) 256-263; DOI: https://doi.org/10.1370/afm.2968
Laura R. Saslow
1Department of Health Behavior and Biological Sciences, School of Nursing, University of Michigan, Ann Arbor, Michigan
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: saslowl@umich.edu
Lenette M. Jones
1Department of Health Behavior and Biological Sciences, School of Nursing, University of Michigan, Ann Arbor, Michigan
PhD, RN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ananda Sen
2Department of Family Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan
3Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia A. Wolfson
4Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
5Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, Michigan
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heidi L. Diez
6Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan
7Pharmacy Innovations and Partnerships, Michigan Medicine, Ann Arbor, Michigan
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alison O’Brien
1Department of Health Behavior and Biological Sciences, School of Nursing, University of Michigan, Ann Arbor, Michigan
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cindy W. Leung
8Department of Nutritional Sciences, School of Public Health, University of Michigan, Ann Arbor, Michigan
ScD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hovig Bayandorian
1Department of Health Behavior and Biological Sciences, School of Nursing, University of Michigan, Ann Arbor, Michigan
MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Daubenmier
9Institute for Holistic Health Studies, San Francisco State University, San Francisco, California
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda L. Missel
1Department of Health Behavior and Biological Sciences, School of Nursing, University of Michigan, Ann Arbor, Michigan
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Richardson
2Department of Family Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Participant CONSORT flow diagram.

    CONSORT = Consolidated Standards of Reporting Trials; COVID-19 = coronavirus disease 2019; DASH = Dietary Approaches to Stop Hypertension; VLC = very low-carbohydrate.

Tables

  • Figures
  • Additional Files
    • View popup
    Table 1.

    Baseline Participant Characteristics

    CharacteristicVLCVLC + SupportDASHDASH + Support
    Sex, No. (%)
        Male8 (34.78)8 (36.36)9 (36.00)9 (37.50)
        Female15 (65.22)14 (63.64)16 (64.00)15 (62.50)
    Age, y60.09 (6.03)55.18 (10.48)58.40 (8.11)60.21 (6.19)
    Race/ethnicity, No. (%), can be >1
        American Indian or Alaska Native1 (4.35)0 (0)0 (0)1 (4.17)
        Asian/Pacific Islander0 (0)0 (0)0 (0)3 (12.50)
        Black4 (17.39)4 (18.18)6 (24.00)5 (20.83)
        Latine0 (0)2 (9.09)1 (4.00)1 (4.17)
        White19 (82.61)18 (81.82)19 (76.00)15 (62.50)
    College graduate, No. (%)20 (86.96)17 (77.27)20 (80.00)17 (70.83)
    Married or long-term partner, No. (%)21 (91.30)17 (77.27)20 (80.00)18 (75.00)
    Total household income, No. (%)
        ≤$35,0000 (0)1 (4.55)3 (12.00)3 (12.50)
        $35,001-$75,0006 (26.09)8 (36.36)4 (16.00)8 (33.33)
        ≥$75,00110 (43.48)12 (54.55)18 (72.00)11 (45.83)
    Smoker, No. (%)0 (0)1 (4.55)0 (0)1 (4.17)
    SBP, mm Hg132.53 (11.13)133.76 (13.71)133.13 (8.58)131.58 (10.85)
    Diastolic BP, mm Hg85.54 (9.54)82.98 (9)80.82 (8.2)82.02 (8.24)
    Weight, lb222.22 (40.53)213.14 (31.64)236.25 (49.61)227.08 (42.77)
    BMI, kg/m235.10 (5.71)35.50 (4.69)37.34 (6.20)35.78 (5.42)
    HbA1c, %6.09 (0.45)6.13 (0.56)6.26 (0.55)5.99 (0.42)
    • BMI = body mass index; BP = blood pressure; DASH = Dietary Approaches to Stop Hypertension; HbA1c = glycated hemoglobin; SBP = systolic blood pressure; VLC = very low-carbohydrate.

    • Note: Data are presented as mean (SD) unless otherwise noted.

    • View popup
    Table 2.

    Estimated Mean (SE) of Outcomes Across Diet and Time From Linear Mixed Model

    OutcomeVLC DietDASH DietDifference
    in Change
    (VLC Lower)
    Between-
    Group P
    Value
    BaselinePostChangeWithin-Group
    P Value
    BaselinePostChangeWithin-Group
    P Value
    SBP, mm Hg133.72
    (1.73)
    123.95
    (1.88)
    −9.77
    (1.66)
    <.001132.84
    (1.69)
    127.66
    (1.80)
    −5.18
    (1.59)
    .002−4.59.046
    HbA1c, %6.09
    (0.07)
    5.74
    (0.08)
    −0.35
    (0.07)
    <.0016.10
    (0.07)
    5.97
    (0.07)
    −0.14
    (0.07)
    .06−0.21.034
    Weight, lb219.24
    (5.39)
    200.10
    (5.41)
    −19.14
    (1.73)
    <.001236.43
    (5.1)
    226.1
    (5.2)
    −10.34
    (1.73)
    <.001−8.81.0003
    • DASH = Dietary Approaches to Stop Hypertension; HbA1c = glycated hemoglobin; SBP = systolic blood pressure; VLC = very low-carbohydrate.

    • Note: Outcomes were analyzed using a linear mixed model including all possible interactions between diet, support, and time and adjusted for age and sex. Results are presented collapsed over all other factors: support allocation, sex, and at the mean value of age. The between-group P value is calculated from a Z-test based on the estimated mean changes and the associated SE values reported in the table.

    • View popup
    Table 3.

    Beta Coefficients and SE Values From Linear Mixed Model

    ParameterSystolic BPHbA1cWeight
    β Coefficient (SE)P Valueβ Coefficient (SE)P Valueβ Coefficient (SE)P Value
    Intercept126.11 (9.23)<.0015.86 (0.37)<.001360.15 (29.96)<.001
    Baseline (vs follow-up)    8.17 (2.23)<.001    0.16 (0.10).1212.55 (2.53)<.001
    VLC (vs DASH) diet    1.99 (3.80).60−0.10 (0.15).52−31.91 (10.76)<.001
    No support (vs support)    7.43 (3.53).04    0.31 (0.14).0310.19 (10.20).32
    Time × diet    0.22 (3.35).95    0.23 (0.15).13    7.64 (3.58).04
    Time × support−5.97 (3.19).07−0.05 (0.14).71−4.43 (3.45).20
    Diet × support−11.40 (5.17).03−0.26 (0.21).2211.84 (14.99).43
    Time × diet × support    8.73 (4.60).06−0.04 (0.20).85    2.34 (4.89).63
    Female (vs male)−3.86 (2.26).09    0.15 (0.09).09−28.50 (7.51)<.001
    Age, y−0.004 (0.14).98−0.002 (0.01).69−2.12 (0.47)<.001
    • BP = blood pressure; DASH = Dietary Approaches to Stop Hypertension; HbA1c = glycated hemoglobin; VLC = very low-carbohydrate.

    • View popup
    Table 4.

    Estimated Mean (SE) of Outcomes Across Support Groups and Time From Linear Mixed Model

    OutcomeExtra SupportNo Extra SupportDifference
    in Change
    (Extra Lower)
    Between-
    Group P
    Value
    BaselinePostChangeWithin-Group
    P Value
    BaselinePostChangeWithin-Group
    P Value
    SBP, mm Hg133.22
    (1.74)
    124.94
    (1.90)
    −8.28
    (1.68)
    <.001133.35
    (1.67)
    126.67
    (1.78)
    −6.68
    (1.57)
    <.001−1.60.49
    HbA1c, %6.04
    (0.07)
    5.76
    (0.08)
    −0.28
    (0.08)
    <.0016.15
    (0.07)
    5.94
    (0.07)
    −0.21
    (0.07)
    .004−0.07.51
    Weight, lb221.41
    (5.31)
    205.04
    (5.36)
    −16.37
    (1.79)
    <.001234.26
    (5.22)
    221.15
    (5.24)
    −13.11
    (1.66)
    <.001−3.26.18
    • HbA1c = glycated hemoglobin; SBP = systolic blood pressure.

    • Note: Outcomes were analyzed using a linear mixed model including all possible interactions between diet, support, and time and adjusted for age and sex. Results are presented collapsed over all other factors: diet, sex, and at the mean value of age. The between-group P value is calculated from a Z test based on the estimated mean changes and the associated SE values reported in the table.

    • View popup
    Table 5.

    Drug Regimen Changes for Participants Taking Drugs During Trial

    Outcomen/N (%)
    VLCVLC + SupportDASHDASH + Support
    BP drugs (n = 72)
        Discontinued or decreased5/16 (31.3)7/16 (43.8)3/23 (13.0)1/19 (5.3)
        No change8/16 (50.0)6/16 (37.5)15/23 (65.2)12/19 (63.2)
        Increased2/16 (12.5)1/16 (6.3)2/23 (8.7)    NA
        Missing1/16 (6.3)2/16 (12.5)3/23 (13.0)6/19 (31.6)
    Blood glucose drugs (n = 24)
        Discontinued or decreased2/5 (40.0)3/4 (75.0)    NA    NA
        No change2/5 (40.0)    NA8/10 (80.0)3/6 (50.0)
        Increased    NA    NA2/10 (20.0)    NA
        Missing1/5 (20.0)1/4 (25.0)    NA3/6 (50.0)
    • BP = blood pressure; DASH = Dietary Approaches to Stop Hypertension; NA = not applicable; VLC = very low-carbohydrate.

    • Note: NA indicates no participants in the category.

Additional Files

  • Figures
  • Tables
  • VISUAL ABSTRACT IN PFG FILE BELOW

    • 21.3_saslow_v04.png -

      PNG file

PreviousNext
Back to top

In this issue

The Annals of Family Medicine: 21 (3)
The Annals of Family Medicine: 21 (3)
Vol. 21, Issue 3
May/June 2023
  • Table of Contents
  • Index by author
  • Front Matter (PDF)
  • Plain-Language Summaries
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparing Very Low-Carbohydrate vs DASH Diets for Overweight or Obese Adults With Hypertension and Prediabetes or Type 2 Diabetes: A Randomized Trial
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Comparing Very Low-Carbohydrate vs DASH Diets for Overweight or Obese Adults With Hypertension and Prediabetes or Type 2 Diabetes: A Randomized Trial
Laura R. Saslow, Lenette M. Jones, Ananda Sen, Julia A. Wolfson, Heidi L. Diez, Alison O’Brien, Cindy W. Leung, Hovig Bayandorian, Jennifer Daubenmier, Amanda L. Missel, Caroline Richardson
The Annals of Family Medicine May 2023, 21 (3) 256-263; DOI: 10.1370/afm.2968

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
Comparing Very Low-Carbohydrate vs DASH Diets for Overweight or Obese Adults With Hypertension and Prediabetes or Type 2 Diabetes: A Randomized Trial
Laura R. Saslow, Lenette M. Jones, Ananda Sen, Julia A. Wolfson, Heidi L. Diez, Alison O’Brien, Cindy W. Leung, Hovig Bayandorian, Jennifer Daubenmier, Amanda L. Missel, Caroline Richardson
The Annals of Family Medicine May 2023, 21 (3) 256-263; DOI: 10.1370/afm.2968
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Strengthening transparency in randomised trials related to multimorbidity: key points and recommendations to guide reporting
  • New Insights and Future Directions: The Importance of Considering Poverty in Studies of Obesity and Diabetes
  • Google Scholar

More in this TOC Section

  • Authorship Inequity in Global Health Research Conducted in Low- and Middle-Income Countries and Published in High-Income Country Family Medicine Journals
  • Feasibility and Acceptability of Implementing a Digital Cognitive Assessment for Alzheimer Disease and Related Dementias in Primary Care
  • Hearing Screening in Private Family Practice Medicine Using Tablet Applications
Show more Original Research

Similar Articles

Subjects

  • Domains of illness & health:
    • Chronic illness
    • Prevention
  • Person groups:
    • Older adults
  • Methods:
    • Quantitative methods
  • Other topics:
    • Multimorbidity

Keywords

  • type 2 diabetes
  • hypertension
  • obesity
  • diet
  • very low-carbohydrate diet
  • DASH diet

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine